Medical Condition

ulcerative colitis uc

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 4, Phase 1, Phase 2, Phase 1

ClinicalMetric tracks all active clinical trials for ulcerative colitis uc sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — ulcerative colitis uc Clinical Trials

How many clinical trials are currently recruiting for ulcerative colitis uc?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for ulcerative colitis uc, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for ulcerative colitis uc?

ulcerative colitis uc research spans Phase 1 (3 trials), Phase 2 (4 trials), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a ulcerative colitis uc clinical trial?

Eligibility criteria for ulcerative colitis uc trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 4

Top Sponsors

University Hospital Schleswig-Holstein 1 trial

Maastricht University Medical Center 1 trial

Xencor, Inc. 1 trial

National Hepatology & Tropical Medicine Research Institute 1 trial

Beijing VDJBio Co., LTD. 1 trial

Recruiting Clinical Trials

NCT07235904 Phase 4

Recruiting

Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis

University Hospital Schleswig-...

View Trial →

NCT07647640

Recruiting

Prospective Evaluation of Flare Detection in IBD With Digital Biomarkers: Bring Your Own Device Study

Maastricht University Medical ...

View Trial →

NCT06619990 Phase 1, Phase 2

Recruiting

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Enrollment

270 pts

Location

United States, Argen...

The Efficacy of Lactobacillous Probiotic and Trace Elements in the Management of Ulcerative Colitis Patients the Patients Will be Recruited From Outpatient Clinic of Inflammatory Bowel Disease (IBD) of the National Hepatology and Tropical Medicine Research Institute NHTMRI, Cairo, Egypt

National Hepatology & Tropical...

View Trial →

NCT07932691 Phase 1

Recruiting

Phase I Trial of Subcutaneous VDJ010 In Healthy Subjects and Patients With Ulcerative Colitis

Beijing VDJBio Co., LTD.

View Trial →

NCT06095596

Recruiting

Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis

Sixth Affiliated Hospital, Sun...

View Trial →

NCT07913347 Phase 1, Phase 2

Recruiting

Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)

Metagen Therapeutics, Inc.

View Trial →

NCT07621783

Recruiting

Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context

Imelda GI Clinical Research Ce...

View Trial →

NCT07237516

Recruiting

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

University of North Carolina, ...

View Trial →

NCT07814456 Phase 2

Recruiting

Fecal Microbiota Transplantation for Ulcerative Colitis Using Dai and Han Donors

First Affiliated Hospital of K...

View Trial →

NCT06992453

Recruiting

Multi-omics Dissection of Gut Microbiome Engraftment During FMT

Catholic University of the Sac...

View Trial →

NCT07113522 Phase 2

Recruiting

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Enrollment

140 pts

Location

United States, Canad...

Sponsor

Mirador Therapeutics, Inc.

View Trial →

Related Conditions

inflammatory bowel disease ibd (3) crohn disease cd (2) ulcerative colitis active moderate (1) crohn s disease cd (1) indeterminate colitis (1) inflammatory bowel disease (1) recurrent c difficile rcdi (1) metabolic syndrome mets (1) crohn s disease (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology